TECH
Bio-Techne Corporation · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +10.0% ·
share flow +15.8% ·
net new positions +9.1%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 147 | +11 | 118.94M | $8.37B | +19 | −7 |
| Q1 2026 | 138 | +4 | 119.63M | $6.27B | +11 | −8 |
| Q4 2025 | 133 | -3 | 119.40M | $7.02B | +1 | −3 |
| Q3 2025 | 21 | +2 | 61.92M | $3.44B | +4 | −3 |
| Q2 2025 | 17 | 0 | 59.03M | $3.04B | +2 | −2 |
| Q1 2025 | 14 | +2 | 27.35M | $1.60B | +3 | −1 |
| Q4 2024 | 12 | 0 | 29.06M | $2.09B | +1 | −1 |
| Q3 2024 | 11 | +1 | 22.54M | $1.80B | +2 | −1 |
| Q2 2024 | 10 | — | 19.47M | $1.39B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 9.42M | +10.5% | $753.29M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 9.42M | +10.5% | $753.29M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 3.90M | -0.1% | $310.93M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 3.90M | -0.1% | $310.93M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Norges Bank ✦ (passive) | 1.90M | 0.0% | $152.20M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Marshall Wace ✦ | 1.76M | -11.1% | $140.90M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 7 | Marshall Wace ✦ | 1.76M | -11.1% | $140.90M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.53M | -8.8% | $122.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 1.53M | -8.8% | $122.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 1.53M | -8.8% | $122.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 1.53M | -8.8% | $122.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Millennium Management ✦ | 1.27M | +13.1% | $101.67M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 1.20M | +367.0% | $96.27M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 1.20M | +367.0% | $96.27M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 1.12M | New | $89.72M | 0.3% | New | 1 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 323.50K | New | $25.86M | 0.0% | New | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 58.09K | +15.7% | $4.59M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 58.09K | +15.7% | $4.59M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 35.60K | +0.3% | $2.85M | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $89.72M | 0.3% |
| Adage Capital Partners | $25.86M | 0.0% |
Exited
| D. E. Shaw & Co. | $239,956 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 426.80K shares, $22,304 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.